New York confirms first case of new mpox strain
The New York State Department of Health recently issued a health advisory regarding the emergence of a new strain of mpox, formerly known as monkeypox. The first case of mpox clade Ib in New York State was confirmed in an individual who had recently traveled from Africa. Despite this development, the department assured the public that the current risk remains low, with no additional known community cases of this strain in the state.
State Health Commissioner Dr. James McDonald stated that the infected individual is currently under isolation and receiving medical care until symptoms fully resolve. He also mentioned that the JYNNEOS vaccine, a two-dose preventative vaccine series for mpox, is expected to be effective against this new strain. The vaccine is readily available for individuals at risk, as per a standing order signed last year, and there is no immediate risk to the general public.
The health department advised individuals to check with their local pharmacy or healthcare provider for vaccine availability and to continue monitoring the situation. While mpox is rarely fatal, it can be particularly dangerous for individuals with compromised immune systems, older adults, young children, and pregnant women. Symptoms of mpox include rashes progressing to painful skin lesions, swollen lymph nodes, fever, sore throat, headaches, back pain, low energy, and muscle aches.
Transmission of mpox can occur through close contact with sores, scabs, or rashes, as well as through respiratory droplets, saliva, or mucus of an infected person. Infected individuals are encouraged to isolate until lesions scab over, and new skin forms at the lesion site. Travelers planning to visit regions with reported cases of mpox are advised to consider vaccination with the two doses of JYNNEOS.
Dr. Myles Druckman, global medical director at International SOS, highlighted that several countries in Central and Eastern Africa have reported cases of this strain. He emphasized the importance of vaccination for high-risk individuals, such as healthcare workers with high exposure or those with weakened immune systems. Prevention measures include avoiding skin-to-skin contact with symptomatic individuals, practicing good personal hygiene, and frequent handwashing.
In conclusion, while the emergence of a new strain of mpox raises concerns, health authorities are actively monitoring the situation and taking necessary precautions to prevent its spread. Vaccination and adherence to preventive measures remain crucial in combating the potential threat of mpox. Stay informed and consult healthcare professionals for guidance on protecting yourself and others from this infectious disease.
